Unknown OBSERVATIONAL NCT05027347

Detection of Plasma Circulating Tumor DNA in Gastric Cancer

Sponsor: University Medical Center Ho Chi Minh City (UMC)

Conditions Circulating Tumor DNA (ctDNA) Gastric Cancer

Interventions plasma circulating tumor DNA

Updated 8 times since 2021 Last updated: Apr 27, 2022 Started: Oct 10, 2021 Primary completion: Sep 30, 2023 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Circulating Tumor DNA (ctDNA) and Gastric Cancer, this trial is ongoing. The trial is conducted by University Medical Center Ho Chi Minh City (UMC) and has accumulated 8 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
May 2022 — May 2024 [monthly]

Recruiting
Jan 2022 — May 2022 [monthly]

Recruiting

▶ Show 3 earlier versions

Dec 2021 — Jan 2022 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Oct 2021 — Dec 2021 [monthly]

Not Yet Recruiting
Sep 2021 — Oct 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center Ho Chi Minh City (UMC)

Data source: University Medical Center Ho Chi Minh City (UMC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ho Chi Minh City, Vietnam